Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord.

Hsu JY, Bourguignon LY, Adams CM, Peyrollier K, Zhang H, Fandel T, Cun CL, Werb Z, Noble-Haeusslein LJ.

J Neurosci. 2008 Dec 10;28(50):13467-77. doi: 10.1523/JNEUROSCI.2287-08.2008.

2.

Extracellular matrix gene expression after vocal fold injury in a rabbit model.

Rousseau B, Ge PJ, Ohno T, French LC, Thibeault SL.

Ann Otol Rhinol Laryngol. 2008 Aug;117(8):598-603.

3.

Three matrix metalloproteinases are required in vivo for macrophage migration during embryonic development.

Tomlinson ML, Garcia-Morales C, Abu-Elmagd M, Wheeler GN.

Mech Dev. 2008 Nov-Dec;125(11-12):1059-70. doi: 10.1016/j.mod.2008.07.005. Epub 2008 Jul 18.

4.

Retroviral-based gene therapy with cyclooxygenase-2 promotes the union of bony callus tissues and accelerates fracture healing in the rat.

Rundle CH, Strong DD, Chen ST, Linkhart TA, Sheng MH, Wergedal JE, Lau KH, Baylink DJ.

J Gene Med. 2008 Mar;10(3):229-41.

PMID:
18088065
5.
6.

Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing.

Simon AM, O'Connor JP.

J Bone Joint Surg Am. 2007 Mar;89(3):500-11.

PMID:
17332098
7.

Prostaglandin E receptors.

Sugimoto Y, Narumiya S.

J Biol Chem. 2007 Apr 20;282(16):11613-7. Epub 2007 Feb 28. Review.

8.

Cyclooxygenase-2 and tumor biology.

Kanaoka S, Takai T, Yoshida K.

Adv Clin Chem. 2007;43:59-78. Review.

PMID:
17249380
9.

Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice.

Duvall CL, Taylor WR, Weiss D, Wojtowicz AM, Guldberg RE.

J Bone Miner Res. 2007 Feb;22(2):286-97.

10.

Matrix metalloproteinase 9 (MMP-9) is upregulated during scarless wound healing in athymic nude mice.

Manuel JA, Gawronska-Kozak B.

Matrix Biol. 2006 Oct;25(8):505-14. Epub 2006 Aug 16.

PMID:
17010584
11.

Inhibition of cyclooxygenase (COX)-2 affects endothelial progenitor cell proliferation.

Colleselli D, Bijuklic K, Mosheimer BA, Kähler CM.

Exp Cell Res. 2006 Sep 10;312(15):2933-41. Epub 2006 Jun 14.

PMID:
16893539
12.
13.

Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling.

Lee A, Frischer J, Serur A, Huang J, Bae JO, Kornfield ZN, Eljuga L, Shawber CJ, Feirt N, Mansukhani M, Stempak D, Baruchel S, Glade Bender J, Kandel JJ, Yamashiro DJ.

Cancer Res. 2006 Apr 15;66(8):4378-84.

14.

A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.

Ke HZ, Crawford DT, Qi H, Simmons HA, Owen TA, Paralkar VM, Li M, Lu B, Grasser WA, Cameron KO, Lefker BA, DaSilva-Jardine P, Scott DO, Zhang Q, Tian XY, Jee WS, Brown TA, Thompson DD.

J Bone Miner Res. 2006 Apr;21(4):565-75. Epub 2006 Apr 5.

15.

The science of fracture healing.

Einhorn TA.

J Orthop Trauma. 2005 Nov-Dec;19(10 Suppl):S4-6.

PMID:
16479221
16.

Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.

Nakao S, Kuwano T, Tsutsumi-Miyahara C, Ueda S, Kimura YN, Hamano S, Sonoda KH, Saijo Y, Nukiwa T, Strieter RM, Ishibashi T, Kuwano M, Ono M.

J Clin Invest. 2005 Nov;115(11):2979-91. Epub 2005 Oct 20.

17.

EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein.

Fujino H, Regan JW.

Mol Pharmacol. 2006 Jan;69(1):5-10. Epub 2005 Oct 4.

19.

Cytosolic phospholipase A2alpha regulates induction of brain cyclooxygenase-2 in a mouse model of inflammation.

Sapirstein A, Saito H, Texel SJ, Samad TA, O'Leary E, Bonventre JV.

Am J Physiol Regul Integr Comp Physiol. 2005 Jun;288(6):R1774-82. Epub 2005 Feb 17.

20.

Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor.

Ono K, Kaneko H, Choudhary S, Pilbeam CC, Lorenzo JA, Akatsu T, Kugai N, Raisz LG.

J Bone Miner Res. 2005 Jan;20(1):23-9. Epub 2004 Oct 25.

Supplemental Content

Support Center